Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2dd1f5c0cf-trace').style.display = (document.getElementById('cakeErr67f2dd1f5c0cf-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2dd1f5c0cf-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2dd1f5c0cf-code').style.display = (document.getElementById('cakeErr67f2dd1f5c0cf-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2dd1f5c0cf-context').style.display = (document.getElementById('cakeErr67f2dd1f5c0cf-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2dd1f5c0cf-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2dd1f5c0cf-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 10794,
		&#039;title&#039; =&gt; &#039;New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;
&lt;br /&gt;
The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;
&lt;br /&gt;
Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;
&lt;br /&gt;
The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;
&lt;br /&gt;
India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;
&lt;br /&gt;
The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;
&lt;br /&gt;
Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;
&lt;br /&gt;
NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Live Mint, 29 October, 2011, http://www.livemint.com/2011/10/28223631/New-pharma-policy-to-cap-price.html?atype=tp&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 10907,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 10794,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health,Governance&#039;,
	&#039;metaDesc&#039; =&gt; &#039;

India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;&lt;br /&gt;The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;&lt;br /&gt;Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;&lt;br /&gt;The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;&lt;br /&gt;India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;&lt;br /&gt;The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;&lt;br /&gt;Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;&lt;br /&gt;NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 10794,
	&#039;title&#039; =&gt; &#039;New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;
&lt;br /&gt;
The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;
&lt;br /&gt;
Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;
&lt;br /&gt;
The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;
&lt;br /&gt;
India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;
&lt;br /&gt;
The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;
&lt;br /&gt;
Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;
&lt;br /&gt;
NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Live Mint, 29 October, 2011, http://www.livemint.com/2011/10/28223631/New-pharma-policy-to-cap-price.html?atype=tp&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 10907,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 10794
$metaTitle = &#039;LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;
$metaKeywords = &#039;Health,Governance&#039;
$metaDesc = &#039;

India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee...&#039;
$disp = &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;&lt;br /&gt;The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;&lt;br /&gt;Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;&lt;br /&gt;The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;&lt;br /&gt;India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;&lt;br /&gt;The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;&lt;br /&gt;Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;&lt;br /&gt;NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp; CH Unnikrishnan | Im4change.org</title>
    <meta name="description" content="

India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp; CH Unnikrishnan</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <br /><div align="justify">India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.<br /><br />The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.<br /><br />Currently, the government controls the prices of only 34 essential medicines.<br /><br />The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.<br /><br />India&rsquo;s drug price control order, or DPCO, was previously revised in 1994.<br /><br />The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.<br /><br />Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.<br /><br />NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.<br /><br />&ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.<br /><br />&ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&rdquo;</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2dd1f5c0cf-trace').style.display = (document.getElementById('cakeErr67f2dd1f5c0cf-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2dd1f5c0cf-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2dd1f5c0cf-code').style.display = (document.getElementById('cakeErr67f2dd1f5c0cf-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2dd1f5c0cf-context').style.display = (document.getElementById('cakeErr67f2dd1f5c0cf-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2dd1f5c0cf-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2dd1f5c0cf-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 10794,
		&#039;title&#039; =&gt; &#039;New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;
&lt;br /&gt;
The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;
&lt;br /&gt;
Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;
&lt;br /&gt;
The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;
&lt;br /&gt;
India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;
&lt;br /&gt;
The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;
&lt;br /&gt;
Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;
&lt;br /&gt;
NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Live Mint, 29 October, 2011, http://www.livemint.com/2011/10/28223631/New-pharma-policy-to-cap-price.html?atype=tp&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 10907,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 10794,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health,Governance&#039;,
	&#039;metaDesc&#039; =&gt; &#039;

India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;&lt;br /&gt;The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;&lt;br /&gt;Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;&lt;br /&gt;The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;&lt;br /&gt;India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;&lt;br /&gt;The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;&lt;br /&gt;Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;&lt;br /&gt;NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 10794,
	&#039;title&#039; =&gt; &#039;New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;
&lt;br /&gt;
The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;
&lt;br /&gt;
Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;
&lt;br /&gt;
The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;
&lt;br /&gt;
India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;
&lt;br /&gt;
The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;
&lt;br /&gt;
Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;
&lt;br /&gt;
NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Live Mint, 29 October, 2011, http://www.livemint.com/2011/10/28223631/New-pharma-policy-to-cap-price.html?atype=tp&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 10907,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 10794
$metaTitle = &#039;LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;
$metaKeywords = &#039;Health,Governance&#039;
$metaDesc = &#039;

India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee...&#039;
$disp = &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;&lt;br /&gt;The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;&lt;br /&gt;Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;&lt;br /&gt;The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;&lt;br /&gt;India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;&lt;br /&gt;The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;&lt;br /&gt;Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;&lt;br /&gt;NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp; CH Unnikrishnan | Im4change.org</title>
    <meta name="description" content="

India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp; CH Unnikrishnan</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <br /><div align="justify">India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.<br /><br />The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.<br /><br />Currently, the government controls the prices of only 34 essential medicines.<br /><br />The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.<br /><br />India&rsquo;s drug price control order, or DPCO, was previously revised in 1994.<br /><br />The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.<br /><br />Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.<br /><br />NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.<br /><br />&ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.<br /><br />&ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&rdquo;</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2dd1f5c0cf-trace').style.display = (document.getElementById('cakeErr67f2dd1f5c0cf-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2dd1f5c0cf-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2dd1f5c0cf-code').style.display = (document.getElementById('cakeErr67f2dd1f5c0cf-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2dd1f5c0cf-context').style.display = (document.getElementById('cakeErr67f2dd1f5c0cf-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2dd1f5c0cf-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2dd1f5c0cf-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 10794,
		&#039;title&#039; =&gt; &#039;New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;
&lt;br /&gt;
The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;
&lt;br /&gt;
Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;
&lt;br /&gt;
The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;
&lt;br /&gt;
India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;
&lt;br /&gt;
The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;
&lt;br /&gt;
Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;
&lt;br /&gt;
NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Live Mint, 29 October, 2011, http://www.livemint.com/2011/10/28223631/New-pharma-policy-to-cap-price.html?atype=tp&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 10907,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 10794,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health,Governance&#039;,
	&#039;metaDesc&#039; =&gt; &#039;

India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;&lt;br /&gt;The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;&lt;br /&gt;Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;&lt;br /&gt;The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;&lt;br /&gt;India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;&lt;br /&gt;The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;&lt;br /&gt;Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;&lt;br /&gt;NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 10794,
	&#039;title&#039; =&gt; &#039;New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;br /&gt;
&lt;div align=&quot;justify&quot;&gt;
India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;
&lt;br /&gt;
The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;
&lt;br /&gt;
Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;
&lt;br /&gt;
The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;
&lt;br /&gt;
India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;
&lt;br /&gt;
The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;
&lt;br /&gt;
Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;
&lt;br /&gt;
NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Live Mint, 29 October, 2011, http://www.livemint.com/2011/10/28223631/New-pharma-policy-to-cap-price.html?atype=tp&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 10907,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 10794
$metaTitle = &#039;LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp;amp; CH Unnikrishnan&#039;
$metaKeywords = &#039;Health,Governance&#039;
$metaDesc = &#039;

India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee...&#039;
$disp = &#039;&lt;br /&gt;&lt;div align=&quot;justify&quot;&gt;India&amp;rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&amp;mdash;or 60% of the drugs sold in the country&amp;mdash;under the government&amp;rsquo;s pricing control.&lt;br /&gt;&lt;br /&gt;The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.&lt;br /&gt;&lt;br /&gt;Currently, the government controls the prices of only 34 essential medicines.&lt;br /&gt;&lt;br /&gt;The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.&lt;br /&gt;&lt;br /&gt;India&amp;rsquo;s drug price control order, or DPCO, was previously revised in 1994.&lt;br /&gt;&lt;br /&gt;The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.&lt;br /&gt;&lt;br /&gt;Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.&lt;br /&gt;&lt;br /&gt;NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&amp;rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&amp;rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &amp;ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&amp;rdquo;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp; CH Unnikrishnan | Im4change.org</title>
    <meta name="description" content="

India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp; CH Unnikrishnan</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <br /><div align="justify">India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.<br /><br />The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.<br /><br />Currently, the government controls the prices of only 34 essential medicines.<br /><br />The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.<br /><br />India&rsquo;s drug price control order, or DPCO, was previously revised in 1994.<br /><br />The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.<br /><br />Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.<br /><br />NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.<br /><br />&ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.<br /><br />&ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&rdquo;</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 10794,
		'title' => 'New pharma policy to cap prices of 60% drugs by Namrata Nandakumar & CH Unnikrishnan',
		'subheading' => '',
		'description' => '<br />
<div align="justify">
India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.<br />
<br />
The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.<br />
<br />
Currently, the government controls the prices of only 34 essential medicines.<br />
<br />
The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.<br />
<br />
India&rsquo;s drug price control order, or DPCO, was previously revised in 1994.<br />
<br />
The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.<br />
<br />
Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.<br />
<br />
NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.<br />
<br />
&ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.<br />
<br />
&ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&rdquo;
</div>',
		'credit_writer' => 'Live Mint, 29 October, 2011, http://www.livemint.com/2011/10/28223631/New-pharma-policy-to-cap-price.html?atype=tp',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 10907,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 10794,
	'metaTitle' => 'LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp; CH Unnikrishnan',
	'metaKeywords' => 'Health,Governance',
	'metaDesc' => '

India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee...',
	'disp' => '<br /><div align="justify">India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.<br /><br />The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.<br /><br />Currently, the government controls the prices of only 34 essential medicines.<br /><br />The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.<br /><br />India&rsquo;s drug price control order, or DPCO, was previously revised in 1994.<br /><br />The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.<br /><br />Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.<br /><br />NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.<br /><br />&ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.<br /><br />&ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&rdquo;</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 10794,
	'title' => 'New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp; CH Unnikrishnan',
	'subheading' => '',
	'description' => '<br />
<div align="justify">
India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.<br />
<br />
The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.<br />
<br />
Currently, the government controls the prices of only 34 essential medicines.<br />
<br />
The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.<br />
<br />
India&rsquo;s drug price control order, or DPCO, was previously revised in 1994.<br />
<br />
The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.<br />
<br />
Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.<br />
<br />
NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.<br />
<br />
&ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.<br />
<br />
&ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&rdquo;
</div>',
	'credit_writer' => 'Live Mint, 29 October, 2011, http://www.livemint.com/2011/10/28223631/New-pharma-policy-to-cap-price.html?atype=tp',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'new-pharma-policy-to-cap-prices-of-60-drugs-by-namrata-nandakumar-ch-unnikrishnan-10907',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 10907,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 10794
$metaTitle = 'LATEST NEWS UPDATES | New pharma policy to cap prices of 60% drugs by Namrata Nandakumar &amp; CH Unnikrishnan'
$metaKeywords = 'Health,Governance'
$metaDesc = '

India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.

The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee...'
$disp = '<br /><div align="justify">India&rsquo;s new pharmaceutical policy seeks to bring at least 400 essential medicines&mdash;or 60% of the drugs sold in the country&mdash;under the government&rsquo;s pricing control.<br /><br />The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing.<br /><br />Currently, the government controls the prices of only 34 essential medicines.<br /><br />The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines.<br /><br />India&rsquo;s drug price control order, or DPCO, was previously revised in 1994.<br /><br />The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share.<br /><br />Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value.<br /><br />NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health.<br /><br />&ldquo;With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,&rdquo; the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access.<br /><br />&ldquo;We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,&rdquo; said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. &ldquo;Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.&rdquo;</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

New pharma policy to cap prices of 60% drugs by Namrata Nandakumar & CH Unnikrishnan

India’s new pharmaceutical policy seeks to bring at least 400 essential medicines—or 60% of the drugs sold in the country—under the government’s pricing control. The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing. Currently, the government controls the prices of only 34 essential medicines. The draft says the policy, to be finalized in a month, will cover nearly all the 348 medicines in the 2005 list. Based on updated data, the list will be expanded to cover about 400 drugs to increase access and availability of essential medicines. India’s drug price control order, or DPCO, was previously revised in 1994. The policy seeks to change how prices of essential medicines are regulated by basing the rates on the updated national list of essential medicines, 2011, or NLEM-2011. The present policy regulates prices based on market share. Under the new policy, drug formulations will be priced by fixing a ceiling on the basis of the weighted average price of the top three brands by value. NLEM-2011 lists at least 450 drug formulations against a total of 663 medicines being sold in India. Total annual turnover of the drugs likely to come under the control of the proposed policy is about Rs.29,000 crore, as per data available with pharma market researcher IMS-Health. “With the implementation of present methodology of price control as stipulated in the new policy, the ceiling prices of formulations will be fixed below the current highest market prices by 0-5% for over 50% of the medicines of the NLEM-2011 and this reduction will be more than 20% for over 30% of such medicines,” the draft policy says. The National Pharmaceuticals Pricing Authority (NPPA) will remain the implementing authority for the new policy and the new drugs (Price Control) order. In due course, DPCO, now mandated under the Essential Commodities Act, will be replaced by specific legislation covering price control. The pharma industry says the government is sacrificing long-term availability of drugs to promote access. “We support the twin objectives of ensuring access and availability as long as the mechanism to achieve them adopts a balanced approach,” said Dilip G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry lobby representing local drugmakers. “Access needs reasonable prices. Availability requires investment in research and development and manufacturing to augment supply of medicines.”